Pivotal TherapeuticsCompany Review & Valuation

PVTTF
OTC Markets
Latest Price
0.00USD
Market Capitalization
201.17kUSD

About Pivotal Therapeutics Inc.

Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coroShow morenary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.Show less

Industry
Biotechnology
HQ Location
Woodbridge, Canada

Stock Price

Price data not available for Pivotal Therapeutics.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Valneva
Biogen
Grifols
Acorda Therapeutics

back to top